Arkolith/Insider Trading/MLYS/Form 4

Levy Adam Scott

CFO and SecretaryMineralys Therapeutics, Inc. (MLYS) · full profile →Form 4 · filed Feb 20, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 19, 2026Grant(A)40K—$049K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 19, 2026Grant(A)53K—$053K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001933414-26-000037) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML